These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18836401)

  • 1. Now that CFC inhalers for asthma are being pulled off the market, what type of inhalers are replacing them?
    Mayo Clin Womens Healthsource; 2008 Nov; 12(11):8. PubMed ID: 18836401
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA approves new inhaler without CFCs.
    FDA Consum; 2001; 35(4):3. PubMed ID: 11692883
    [No Abstract]   [Full Text] [Related]  

  • 3. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuterol inhalers.
    Gross NJ
    N Engl J Med; 2007 Jun; 356(26):2749; author reply 2749. PubMed ID: 17596614
    [No Abstract]   [Full Text] [Related]  

  • 5. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E; Ekholm BP; Klinger NM; Colice GL
    J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GR106642X: a new, non-ozone depleting propellant for inhalers.
    Taggart SC; Custovic A; Richards DH; Woodcock A
    BMJ; 1995 Jun; 310(6995):1639-40. PubMed ID: 7795451
    [No Abstract]   [Full Text] [Related]  

  • 8. Switching to CFC-free inhalers.
    Weller T
    Prof Nurse; 1999 Nov; 15(2):73. PubMed ID: 10765307
    [No Abstract]   [Full Text] [Related]  

  • 9. A neglected breakthrough in asthma therapy.
    Brown HM
    Lancet; 2003 Feb; 361(9355):433-4. PubMed ID: 12573409
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible replacements for CFC-propelled metered-dose inhalers.
    Dalby RN
    Med Device Technol; 1991 May; 2(4):21-5. PubMed ID: 10149436
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparing for a change in metered-dose inhalers. National Asthma Education and Prevention Program CFC Phaseout Working Group.
    Minn Med; 1998 Feb; 81(2):26-7. PubMed ID: 9505495
    [No Abstract]   [Full Text] [Related]  

  • 12. Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients.
    Langley SJ; Houghton CM; Singh SD
    Respiration; 2005; 72 Suppl 1():35-7. PubMed ID: 15915011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues surrounding MDI formulation development with non-CFC propellants.
    Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
    J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
    Braunstein G; Sharma R
    Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting drug delivery and the small airways in asthma.
    Williams A
    Hosp Med; 1998 Jun; 59(6):488-91. PubMed ID: 9775278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D
    Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CFC Phase-Out and the Chiesi Solution.
    Huchon G; Fabbri LM
    Respiration; 2005; 72 Suppl 1():1-2. PubMed ID: 15915005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bronchial asthma. Small bronchi are not spared].
    MMW Fortschr Med; 2002 May; 144(18):64. PubMed ID: 12422715
    [No Abstract]   [Full Text] [Related]  

  • 19. Asthma's new expense. Phaseout of inhaler leaves patients gasping with sticker shock.
    Lavelle M
    US News World Rep; 2007 Aug; 143(6):66-7. PubMed ID: 18019967
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.